cro.directory
← Compare landing

Ardena vs Scinai Immunotherapeutics Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ardena/scinai-immunotherapeutics

CategoryArdenaScinai Immunotherapeutics Ltd.
Listed sitebothboth
SummaryArdena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Oral Solid Dosage Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • CMC Regulatory Submission Support
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Analytical Development
  • Process Development
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.
  • Dermatology
  • Immunology
  • Rare Disease
Locations
  • Ghent, Ghent, Belgium
  • Oss, Oss, Netherlands
  • Assen, Assen, Netherlands
  • Pamplona, Pamplona, Spain
  • Somerset, Somerset, New Jersey, United States
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
CertificationsData not yet provided.
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.